Logo image of MCFT

MASTERCRAFT BOAT HOLDINGS IN (MCFT) Stock Fundamental Analysis

NASDAQ:MCFT - Nasdaq - US57637H1032 - Common Stock - Currency: USD

16.2  +0.2 (+1.25%)

After market: 16.2 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MCFT. MCFT was compared to 30 industry peers in the Leisure Products industry. MCFT is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. MCFT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MCFT was profitable.
MCFT had a positive operating cash flow in the past year.
Of the past 5 years MCFT 4 years were profitable.
Each year in the past 5 years MCFT had a positive operating cash flow.
MCFT Yearly Net Income VS EBIT VS OCF VS FCFMCFT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

MCFT has a Return On Assets of -2.67%. This is comparable to the rest of the industry: MCFT outperforms 53.33% of its industry peers.
The Return On Equity of MCFT (-3.75%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 2.06%, MCFT perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MCFT is significantly above the industry average of 8.15%.
The 3 year average ROIC (30.44%) for MCFT is well above the current ROIC(2.06%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.67%
ROE -3.75%
ROIC 2.06%
ROA(3y)13.84%
ROA(5y)10.06%
ROE(3y)26.89%
ROE(5y)16.74%
ROIC(3y)30.44%
ROIC(5y)27.79%
MCFT Yearly ROA, ROE, ROICMCFT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 150

1.3 Margins

In the last couple of years the Profit Margin of MCFT has declined.
MCFT's Operating Margin of 1.65% is in line compared to the rest of the industry. MCFT outperforms 53.33% of its industry peers.
MCFT's Operating Margin has declined in the last couple of years.
MCFT has a worse Gross Margin (16.88%) than 86.67% of its industry peers.
MCFT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.65%
PM (TTM) N/A
GM 16.88%
OM growth 3Y-32.32%
OM growth 5Y-17.63%
PM growth 3Y-43.91%
PM growth 5Y-14.25%
GM growth 3Y-11.99%
GM growth 5Y-5.47%
MCFT Yearly Profit, Operating, Gross MarginsMCFT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MCFT is creating value.
The number of shares outstanding for MCFT has been reduced compared to 1 year ago.
MCFT has less shares outstanding than it did 5 years ago.
MCFT has a worse debt/assets ratio than last year.
MCFT Yearly Shares OutstandingMCFT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MCFT Yearly Total Debt VS Total AssetsMCFT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

MCFT has an Altman-Z score of 4.39. This indicates that MCFT is financially healthy and has little risk of bankruptcy at the moment.
MCFT has a Altman-Z score of 4.39. This is amongst the best in the industry. MCFT outperforms 83.33% of its industry peers.
There is no outstanding debt for MCFT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.39
ROIC/WACC0.24
WACC8.63%
MCFT Yearly LT Debt VS Equity VS FCFMCFT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.84 indicates that MCFT should not have too much problems paying its short term obligations.
MCFT has a Current ratio of 1.84. This is in the lower half of the industry: MCFT underperforms 60.00% of its industry peers.
MCFT has a Quick Ratio of 1.23. This is a normal value and indicates that MCFT is financially healthy and should not expect problems in meeting its short term obligations.
MCFT has a Quick ratio of 1.23. This is comparable to the rest of the industry: MCFT outperforms 43.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.84
Quick Ratio 1.23
MCFT Yearly Current Assets VS Current LiabilitesMCFT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2

3. Growth

3.1 Past

The earnings per share for MCFT have decreased strongly by -84.59% in the last year.
MCFT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.07% yearly.
MCFT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -45.70%.
MCFT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.70% yearly.
EPS 1Y (TTM)-84.59%
EPS 3Y-29.37%
EPS 5Y-16.07%
EPS Q2Q%-72.97%
Revenue 1Y (TTM)-45.7%
Revenue growth 3Y-7.69%
Revenue growth 5Y-4.7%
Sales Q2Q%-36.3%

3.2 Future

Based on estimates for the next years, MCFT will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.59% on average per year.
The Revenue is expected to decrease by -2.37% on average over the next years.
EPS Next Y-36.65%
EPS Next 2Y11.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-20.64%
Revenue Next 2Y-2.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MCFT Yearly Revenue VS EstimatesMCFT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
MCFT Yearly EPS VS EstimatesMCFT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.45 indicates a quite expensive valuation of MCFT.
MCFT's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.63, MCFT is valued at the same level.
With a Price/Forward Earnings ratio of 11.12, the valuation of MCFT can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MCFT indicates a somewhat cheap valuation: MCFT is cheaper than 80.00% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.85. MCFT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 29.45
Fwd PE 11.12
MCFT Price Earnings VS Forward Price EarningsMCFT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

MCFT's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.81
MCFT Per share dataMCFT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.59%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MCFT!.
Industry RankSector Rank
Dividend Yield N/A

MASTERCRAFT BOAT HOLDINGS IN

NASDAQ:MCFT (4/21/2025, 8:00:00 PM)

After market: 16.2 0 (0%)

16.2

+0.2 (+1.25%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)02-06 2025-02-06/bmo
Earnings (Next)05-07 2025-05-07/bmo
Inst Owners92.5%
Inst Owner Change-0.26%
Ins Owners2.54%
Ins Owner Change1.03%
Market Cap271.35M
Analysts76.67
Price Target23.05 (42.28%)
Short Float %4.91%
Short Ratio10.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3141.2%
Min EPS beat(2)311.79%
Max EPS beat(2)5970.61%
EPS beat(4)4
Avg EPS beat(4)1605.82%
Min EPS beat(4)58.7%
Max EPS beat(4)5970.61%
EPS beat(8)8
Avg EPS beat(8)818.63%
EPS beat(12)12
Avg EPS beat(12)550.17%
EPS beat(16)16
Avg EPS beat(16)417.82%
Revenue beat(2)2
Avg Revenue beat(2)3.47%
Min Revenue beat(2)2.2%
Max Revenue beat(2)4.73%
Revenue beat(4)4
Avg Revenue beat(4)3.11%
Min Revenue beat(4)1.09%
Max Revenue beat(4)4.73%
Revenue beat(8)8
Avg Revenue beat(8)2.97%
Revenue beat(12)10
Avg Revenue beat(12)2.21%
Revenue beat(16)11
Avg Revenue beat(16)-1.08%
PT rev (1m)0%
PT rev (3m)-1.74%
EPS NQ rev (1m)-1.89%
EPS NQ rev (3m)-37.46%
EPS NY rev (1m)-2.46%
EPS NY rev (3m)-0.26%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-7.45%
Revenue NY rev (1m)0.15%
Revenue NY rev (3m)-1.22%
Valuation
Industry RankSector Rank
PE 29.45
Fwd PE 11.12
P/S 0.93
P/FCF N/A
P/OCF 102.63
P/B 1.52
P/tB 2.32
EV/EBITDA 11.81
EPS(TTM)0.55
EY3.4%
EPS(NY)1.46
Fwd EY8.99%
FCF(TTM)-0.61
FCFYN/A
OCF(TTM)0.16
OCFY0.97%
SpS17.41
BVpS10.65
TBVpS6.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.67%
ROE -3.75%
ROCE 2.53%
ROIC 2.06%
ROICexc 3.09%
ROICexgc 5.98%
OM 1.65%
PM (TTM) N/A
GM 16.88%
FCFM N/A
ROA(3y)13.84%
ROA(5y)10.06%
ROE(3y)26.89%
ROE(5y)16.74%
ROIC(3y)30.44%
ROIC(5y)27.79%
ROICexc(3y)35.88%
ROICexc(5y)32.97%
ROICexgc(3y)55.34%
ROICexgc(5y)62.02%
ROCE(3y)37.33%
ROCE(5y)34.08%
ROICexcg growth 3Y-41.98%
ROICexcg growth 5Y-41.71%
ROICexc growth 3Y-36.32%
ROICexc growth 5Y-19.49%
OM growth 3Y-32.32%
OM growth 5Y-17.63%
PM growth 3Y-43.91%
PM growth 5Y-14.25%
GM growth 3Y-11.99%
GM growth 5Y-5.47%
F-Score4
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 126.42%
Cap/Sales 4.4%
Interest Coverage 2.13
Cash Conversion 17.68%
Profit Quality N/A
Current Ratio 1.84
Quick Ratio 1.23
Altman-Z 4.39
F-Score4
WACC8.63%
ROIC/WACC0.24
Cap/Depr(3y)182.78%
Cap/Depr(5y)184.82%
Cap/Sales(3y)3.83%
Cap/Sales(5y)4.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-84.59%
EPS 3Y-29.37%
EPS 5Y-16.07%
EPS Q2Q%-72.97%
EPS Next Y-36.65%
EPS Next 2Y11.59%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-45.7%
Revenue growth 3Y-7.69%
Revenue growth 5Y-4.7%
Sales Q2Q%-36.3%
Revenue Next Year-20.64%
Revenue Next 2Y-2.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-93.5%
EBIT growth 3Y-37.52%
EBIT growth 5Y-21.5%
EBIT Next Year50.57%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-108.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-98.1%
OCF growth 3Y-43.28%
OCF growth 5Y-25.89%